Vanguard Medicine: Novel Therapies on the Horizon
October 22, 2020 | 02:30 PM - 04:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Clinical Practice Session
Vanguard Medicine: Novel Therapies on the Horizon
October 22, 2020 | 02:30 PM - 04:30 PM
Location: Simulive
Session Description
There are several novel therapies in the pipeline and new indications for approved drugs in the management of glomerular disease, lupus, and obesity. This session reviews mechanisms, risks, and benefits of therapies for several disease processes in CKD.
Learning Objective(s)
- Discuss real-world use and safety signals for novel therapeutics
- Outline emerging indications for approved therapies
Learning Pathway(s)
- Chronic Kidney Disease
- Acute Kidney Injury
Moderators
- Derek M. Fine, MD
- Melanie P. Hoenig, DrMed, MD
Presentations
- New Options for Weight Loss in CKD: Bardoxolone and GLP-1 Agonists
02:30 PM - 03:00 PM
Glenn Matthew Chertow, MD, MPH, FASN
Glenn Matthew Chertow, MD, MPH, FASN
New Options for Weight Loss in CKD: Bardoxolone and GLP-1 Agonists
October 22, 2020 | 02:30 PM - 03:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Emerging Therapies for FSGS
03:00 PM - 03:30 PM
Kirk N. Campbell, MD, FASN
Kirk N. Campbell, MD, FASN
Emerging Therapies for FSGS
October 22, 2020 | 03:00 PM - 03:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Emerging Therapies in Lupus
03:30 PM - 04:00 PM
Patrick H. Nachman, MD, FASN
Patrick H. Nachman, MD, FASN
Emerging Therapies in Lupus
October 22, 2020 | 03:30 PM - 04:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- New Formulations of Gadolinium: Still Contraindicated in Advanced CKD?
04:00 PM - 04:30 PM
Kirsten L. Johansen, MD, FASN
Kirsten L. Johansen, MD, FASN
Dr. Johansen is Chief of Nephrology at Hennepin Healthcare and Professor of Medicine at the University of Minnesota. She is the Director of the United States Renal Data System and co-Director of the Chronic Disease Research Group at Hennepin Healthcare Research Institute.
New Formulations of Gadolinium: Still Contraindicated in Advanced CKD?
October 22, 2020 | 04:00 PM - 04:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
